Media Thread, page-256

It seems that with these two recent announcements (HER-Vax and PD1-Vaxx), outlets are now chasing Leslie for comment.
In the latest 'proactive' interview LC continues to unpack the IMU story - so, so positive.

When asked if we are seeing a new approach to treating cancer she responded by comparing to existing treatments like Keytruda ...
"in terms of platform we're B-Cell activated ... when everyone else is into the T-Cell modulation ... and they are garnering anywhere
between 7-10 Billion dollars (read: huge income !!!) ... however we have what I consider a kinder, gentler approach" (read: 'safer').

"It could be a paradigm shift ... current market for PD1 is roughly enhances patient outlook by 20% - 30% of the patient population
... we are aiming for much higher than that ... maybe double or even triple that effect" (read: O.M.G. !!!)

When asked, when can we see some early data LC replied "In the pre-clinical models we saw a whooping amount of antibody production
... so 3, 6, 9 months ... we could possibly get a signal very soon. (read: don't miss it)

Into the future: We are the pioneers and we are going to keep going because we want to be the leader ... I aim to keep us in
the front-line. (read: we are 'it' in B-Cell)

So there it is, once again, positive, positive news. All IMO and not financial advice of course.